戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erlying lithium-induced nephrogenic diabetes insipidus.
2 its perturbation is associated with diabetes insipidus.
3 hree patients due to development of diabetes insipidus.
4 ownregulation can cause nephrogenic diabetes insipidus.
5 duced, ameliorating the symptoms of diabetes insipidus.
6 pressing neurons, developed central diabetes insipidus.
7  a diagnosis of partial nephrogenic diabetes insipidus.
8  water in health and in nephrogenic diabetes insipidus.
9  necessary in patients with central diabetes insipidus.
10  of mice and a patient with central diabetes insipidus.
11 sed water intake), both features of diabetes insipidus.
12 ive CD8 T cells can trigger central diabetes insipidus.
13 absence of which causes nephrogenic diabetes insipidus.
14 tial therapeutic use in nephrogenic diabetes insipidus.
15 he human vasopressin gene can cause diabetes insipidus.
16 nd hypernatremic dehydration due to diabetes insipidus.
17 log), characteristic of nephrogenic diabetes insipidus.
18 esponsible for X-linked nephrogenic diabetes insipidus.
19 congenital cataracts to nephrogenic diabetes insipidus.
20 duces distinct forms of nephrogenic diabetes insipidus.
21 enesis of familial neurohypophyseal diabetes insipidus.
22 and nodal involvement, and four had diabetes insipidus.
23 or triplets, or subclinical central diabetes insipidus, a transient diabetes insipidus may ensue from
24 diabetes, diabetic ketoacidosis, or diabetes insipidus; a need for renal replacement therapy; severe
25  dominant familial neurohypophyseal diabetes insipidus (adFNDI) is a progressive, inherited neurodege
26  dominant familial neurohypophyseal diabetes insipidus (adFNDI), a rare inherited disorder that prese
27 ite a paucity of published reports, diabetes insipidus after discontinuation of vasopressin infusion
28                    The mechanism of diabetes insipidus after discontinuation of vasopressin infusion
29  investigate the occurrence rate of diabetes insipidus after discontinuation of vasopressin infusion
30         Sixteen of 29 patients with diabetes insipidus after discontinuation of vasopressin infusion
31        To date, very few reports of diabetes insipidus after discontinuation of vasopressin infusion
32              The occurrence rate of diabetes insipidus after discontinuation of vasopressin infusion
33 dings demonstrate the occurrence of diabetes insipidus after discontinuation of vasopressin infusion
34  donor hyperosmolarity secondary to diabetes insipidus, an almost universal occurrence among brain-de
35 somal recessive form of nephrogenic diabetes insipidus and absence of the Colton blood group antigens
36 nistration (FDA) in 1978 for use in diabetes insipidus and bleeding disorders, but it is also prescri
37 s in aquaporins include nephrogenic diabetes insipidus and congenital cataracts.
38 ipolar disorder, causes nephrogenic diabetes insipidus and hypercalcemia in about 20% and 10% of pati
39  mellitus, optic atrophy, deafness, diabetes insipidus and neurological signs.
40 side effects, including nephrogenic diabetes insipidus and rarely, ESRD.
41 fy a novel mechanism of nephrogenic diabetes insipidus and uncover a role of SOCE in renal water hand
42 sis, diagnosis of low-grade glioma, diabetes insipidus, and central precocious puberty were associate
43 k factor for lower scores, but sex, diabetes insipidus, and cranial radiotherapy were not.
44 h as Gaucher's disease, nephrogenic diabetes insipidus, and Creutzfeldt-Jakob disease.
45  origin of optic atrophy, deafness, diabetes insipidus, and incontinence, (2) other previously report
46  growth hormone deficiency, central diabetes insipidus, and male hypogonadism as new features of PCSK
47  Improvement in bone lesions, pain, diabetes insipidus, and other manifestations was gradual over man
48  including hypochloremic alkalosis, diabetes insipidus, and salt-sensitive hypotension, with depletio
49  rats, with hereditary hypothalamic diabetes insipidus, and Sprague-Dawley rats, with normal pituitar
50 rteen months post-OLT she developed diabetes insipidus, bilateral ear discharge, and new osteolytic l
51                          Atherogenesis is an insipidus but precipitating process leading to serious c
52 ocellular cells or a side effect of diabetes insipidus, but favors the hypothesis that central, parvo
53 tal tubular acidosis or nephrogenic diabetes insipidus can be caused by autoantibodies targeting the
54 everal disorders, including central diabetes insipidus (CDI).
55 rophy which is often accompanied by diabetes insipidus, deafness, urological and neurological complic
56 thermore, in a patient with central diabetes insipidus, desmopressin reduced the excretion of ECVs de
57                       Unexpectedly, diabetes insipidus developed in surviving animals.
58  susceptibility for lithium-induced diabetes insipidus development.
59                                     Diabetes insipidus (DI) is a disorder characterized by excretion
60 icated for the treatment of central diabetes insipidus (DI), bedwetting, haemophilia A and von Willeb
61 ity based on the absence of central diabetes insipidus (DI).
62 r beta (LXRbeta) in the etiology of diabetes insipidus (DI).
63 ubsequently emerged, and "DIDMOAD" (diabetes insipidus, diabetes mellitus, optic atrophy, and deafnes
64  donors without clinically apparent diabetes insipidus display a defect in the baroreflex-mediated se
65 t have utility in treating forms of diabetes insipidus (e.g., X-linked nephrogenic diabetes insipidus
66 ntosa, color blindness, nephrogenic diabetes insipidus, familial ACTH resistance, and familial hypoca
67           Familial neurohypophyseal diabetes insipidus (FNDI) in humans is an autosomal dominant diso
68           Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disorder cause
69  dominant familial neurohypophyseal diabetes insipidus (FNDI).
70 ge by the primary disease, LCH (eg, diabetes insipidus, fractures, and tooth loss).
71 s the disease progressed, including diabetes insipidus, growth hormone deficiency, primary hypogonadi
72 tor of GSK3beta, causes nephrogenic diabetes insipidus, GSK3beta may play a crucial role in regulatin
73 r and aquaporin 2 cause nephrogenic diabetes insipidus; however, expression of these genes is maintai
74 omplications, visual complications, diabetes insipidus, hypopituitarism and cranial nerve injury.
75 cts in 42%, dental problems in 30%, diabetes insipidus in 25%, growth failure in 20%, sex hormone def
76 Other features included nephrogenic diabetes insipidus in 87% and hypertension in 33.3%.
77 eptibility gene for lithium-induced diabetes insipidus in mice.
78 tubular toxicity caused nephrogenic diabetes insipidus in one.
79 ation (which could explain acquired diabetes insipidus in patients receiving lithium) is unclear.
80 sipidus (e.g., X-linked nephrogenic diabetes insipidus) in which the kidney responds inappropriately
81 ssociated with familial nephrogenic diabetes insipidus, induces constitutive arrestin-mediated desens
82 mon cause of hereditary nephrogenic diabetes insipidus is a nonfunctional vasopressin (VP) receptor t
83                                     Diabetes insipidus is a syndrome characterized by excretion of ab
84           Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterize
85  dominant familial neurohypophyseal diabetes insipidus is caused by mutations in the arginine vasopre
86                       Postoperative diabetes insipidus is common after pituitary surgery and is typic
87                    This nephrogenic diabetes insipidus leads to dehydration and death of nursing mice
88 2 blocker that causes a nephrogenic diabetes insipidus-like excessive loss of hypotonic urine.
89 VP misfolding in hereditary central diabetes insipidus likely shares common physiopathological mechan
90  reduce lithium-induced nephrogenic diabetes insipidus (lithium-NDI), patients with bipolar disorder
91  iron overload leads to nephrogenic diabetes insipidus marked by AVP-resistant urinary concentrating
92 ral diabetes insipidus, a transient diabetes insipidus may ensue from this vasopressinase-mediated de
93 sms underlying the pathogenicity of diabetes insipidus mutations were probed by studying their effect
94 oint mutants that cause nephrogenic diabetes insipidus (NDI) are retained in the endoplasmic reticulu
95 f a variety of acquired nephrogenic diabetes insipidus (NDI) disorders have identified a common featu
96              Congenital nephrogenic diabetes insipidus (NDI) is a rare disease caused most often by m
97                         Nephrogenic diabetes insipidus (NDI) is caused by impairment of vasopressin (
98 Hereditary non-X-linked nephrogenic diabetes insipidus (NDI) is caused by mutations in the aquaporin-
99 imal models of acquired nephrogenic diabetes insipidus (NDI) that loss of the aquaporin-2 (AQP2) prot
100 with partial congenital nephrogenic diabetes insipidus (NDI) that resulted from a mutation in the aqu
101 that cause non-X-linked nephrogenic diabetes insipidus (NDI) were characterized to establish the cell
102 ed with lithium develop nephrogenic diabetes insipidus (NDI), a disorder characterized by polyuria an
103 ntrating ability, i.e., nephrogenic diabetes insipidus (NDI), but the molecular mechanism is unknown.
104 ansgenic mouse model of nephrogenic diabetes insipidus (NDI), we have analyzed the mouse aquaporin-2
105  trafficking results in nephrogenic diabetes insipidus (NDI).
106 uce autosomal recessive nephrogenic diabetes insipidus (NDI).
107 ce with lithium-induced nephrogenic diabetes insipidus (NDI).
108              Congenital nephrogenic diabetes insipidus (NDI; also known as arginine vasopressin resis
109  possibility of sevoflurane-induced diabetes insipidus not only during general anesthesia but also in
110 e central adrenal insufficiency and diabetes insipidus occurred in some patients.
111 owed by a hyperdynamic response and diabetes insipidus, occurred in every animal following brain deat
112 e treatment of choice for transient diabetes insipidus of pregnancy.
113 poarousal could be a side effect of diabetes insipidus - polydipsia and polyuria seen in Hom rats due
114           One patient developed new diabetes insipidus post-operatively.
115 had severe polyuria and nephrogenic diabetes insipidus, potentially due to greatly reduced AQP2 and A
116 many countries for the treatment of diabetes insipidus, primary nocturnal enuresis, nocturia, and coa
117 ngs establish a form of nephrogenic diabetes insipidus produced by impaired water permeability in col
118 e effects, Grhl2-deficient mice had diabetes insipidus, produced dilute urine, and failed to adequate
119 d with Charcot-Marie-Tooth disease, diabetes insipidus, retinitis pigmentosa, cystic fibrosis, and se
120         He was later diagnosed with diabetes insipidus, spastic quadriplegia, developmental delay, ag
121 dren affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inheritance.
122                     The nephrogenic diabetes insipidus symptoms and the absence of developmental defe
123 in an AVP-deficient animal model of diabetes insipidus (the Brattleboro rat), which allowed us to mon
124 lecular determinant for nephrogenic diabetes insipidus, the vasopressin receptor with a substitution
125                                     Diabetes insipidus was evaluated in 21 patients; it was confirmed
126 donors without clinical evidence of diabetes insipidus; we also investigated the vasopressor effect o
127 nomenon, hyperdynamic response, and diabetes insipidus were observed in each animal after BD.
128 or treatment of shock, criteria for diabetes insipidus were observed in two of 1,320 subjects (0.15%)
129 esponsible for X-linked nephrogenic diabetes insipidus were used as model systems.
130 rginine vasopressin (AVP) underlies diabetes insipidus, which is characterized by the excretion of ab
131 epresent a new model of nephrogenic diabetes insipidus with unique molecular etiology, and we have id
132 known to cause X-linked nephrogenic diabetes insipidus (XNDI) in humans (Glu242stop) into the mouse g
133                X-linked nephrogenic diabetes insipidus (XNDI) is a severe kidney disease caused by in

 
Page Top